Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer

Published:2016-01 Issue:1 Volume:27 Page:106-113
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

O'Shaughnessy J.,Campone M.,Brain E.,Neven P.,Hayes D.,Bondarenko I.,Griffin T.W.,Martin J.,De Porre P.,Kheoh T.,Yu M.K.,Peng W.,Johnston S.

Funder

Janssen Research & Development

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/1/106/6676593/mdv487.pdf

Reference14 articles.

1. Understanding the mechanisms of aromatase inhibitor resistance;Miller;Breast Cancer Res,2012

2. Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer;Madeira;BMC Cancer,2013

3. Expression of androgen receptors in primary breast cancer;Park;Ann Oncol,2010

4. Androgen receptor expression and breast cancer survival in postmenopausal women;Hu;Clin Cancer Res,2011

5. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells;De;Breast Cancer Res Treat,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes;Life Sciences;2024-07

2. Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer;The Lancet Oncology;2024-03

3. Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer;International Journal of Molecular Sciences;2024-02-02

4. Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients;Archives of Gynecology and Obstetrics;2023-10-30

5. Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific Survival;Advances in Therapy;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3